Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
|
|
RenovoRx, Inc. (RNXT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Nelms Angela (COO) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Bought 300 shares
@ $1.0499, valued at
$315
Bought 800 shares
@ $1.045, valued at
$836 |
|
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 43,026 options to buy
@ $2.74, valued at
$117.9k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| RYAN UNA S (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
| 10/04/2022 |
4
| Marton Laurence (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
| 10/04/2022 |
4
| Macfarlane K. Angela (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
| 10/04/2022 |
4
| Diamond David (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 25,099 options to buy
@ $2.02, valued at
$50.7k
|
|
| 09/21/2022 |
4
| Nelms Angela (COO) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 274,230 options to buy
@ $2.42, valued at
$663.6k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Marton Laurence (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 4,582 options to buy
@ $3.17, valued at
$14.5k
|
|
| 03/14/2022 |
4
| Macfarlane K. Angela (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 4,582 options to buy
@ $3.17, valued at
$14.5k
|
|
| 03/14/2022 |
4
| Diamond David (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 4,582 options to buy
@ $3.17, valued at
$14.5k
Granted 9,165 options to buy
@ $3.17, valued at
$29.1k
|
|
| 03/14/2022 |
4
| Agah Ramtin (Chief Medical Officer) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 21,398 options to buy
@ $3.17, valued at
$67.8k
|
|
| 03/14/2022 |
4
| Bagai Shaun (CEO) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 48,313 options to buy
@ $3.17, valued at
$153.2k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Marton Laurence (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 11,154 options to buy
@ $5.91, valued at
$65.9k
|
|
| 10/05/2021 |
4
| Macfarlane Kirsten Angela (Director) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 11,154 options to buy
@ $5.91, valued at
$65.9k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2021 |
4
| Agah Ramtin (Chief Medical Officer) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 52,203 options to buy
@ $6.04, valued at
$315.3k
|
|
| 10/04/2021 |
4
| Bagai Shaun (CEO) has filed a Form 4 on RenovoRx, Inc.|
Txns:
| Granted 117,866 options to buy
@ $6.04, valued at
$711.9k
|
|
|
|